Assessing the Role of a Fermented Soy Extract in Inflammation and the Human Microbiome

Completed · Phase 1

Conditions studied: Obesity

In brief

The consumption of fermented soy foods can alter the human microbiome and may confer health benefits. Researchers propose a line of inquiry to assess the effects of Q-Can Plus ("QC") fermented soy beverage in humans, assessing immunological, microbiological, and clinical parameters.

Key facts

Study ID
NCT02656056
Run by
Yale University
People needed
22
Starts
2016-01-01
Expected to finish
2017-06-01
Last updated by the study team
2018-05-11

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.